Skip to main content
SpringerLink
Log in

Low Molecular Mass Permeation Enhancers in Oral Delivery of Macromolecular Drugs

  • Chapter
  • First Online:
Book cover Oral Delivery of Macromolecular Drugs

Abstract

Within the last decades strong evidence has been provided on the potential of various types of low molecular mass permeation enhancers to improve the oral uptake of macromolecular drugs. Although a considerable number of low molecular mass permeation enhancers have been developed, medium-chain fatty acids can still be regarded as gold standard. The development of more potent and less toxic low molecular mass permeation enhancers is therefore highly on demand. Moreover, drug delivery systems providing synchronized release properties of both drug and permeation enhancer and additional favourable features such as protective and mucoadhesive properties contribute to an improved oral drug uptake. Having the great potential of low molecular mass permeation enhancers in mind and taking all the opportunities ahead into consideration, this class of permeation enhancers will certainly further alter the landscape of drug delivery towards more efficient therapeutic systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderberg EK, Lindmark T, Artursson P (1993) Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res 10:857–864

    Article  PubMed  CAS  Google Scholar 

  • Aungst BJ, Rogers NJ (1988) Site dependence of absorption-promoting actions of Laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res 5:305–308

    Article  PubMed  CAS  Google Scholar 

  • Aungst BJ, Saitoh H, Burcham DL, Huang S-M, Mousa SA, Hussain MA (1996) Enhancement of the intestinal absorption of peptides and non-peptides. J Contr Rel 41:19–31

    Article  CAS  Google Scholar 

  • Baluom M, Friedman M, Rubinstein A (1998) The importance of intestinal residence time of absorption enhancer on drug absorption and implication on formulative considerations. Int J Pharm 176:21–30

    Article  CAS  Google Scholar 

  • Baudry B, Fasano A, Ketley J, Kaper JB (1992) Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun 60:428–434

    PubMed  CAS  Google Scholar 

  • Bernkop-Schnürch A, Krajicek ME (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates J Control Rel 50:215–23

    Article  Google Scholar 

  • Bowe CL, Mokhtarzadeh L, Venkatesan P, Babu S, Axelrod HR, Sofia MJ, Kakarla R, Chan TY, Kim JS, Lee HJ, et al. (1997) Design of compounds that increase the absorption of polar molecules. Proc Natl Acad Sci USA 94:12218–12223

    Article  PubMed  CAS  Google Scholar 

  • Brayden D, Creed E, O’Connell A, Leipold H, Argawal R, Leone-Bay A (1997) Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm Res 14:1772–1779

    Article  PubMed  CAS  Google Scholar 

  • Burcham DL, Aungst BJ, Hussain M, Gorko MA, Quon CY, Huang S-M (1995) The effect of absorption enhancers on the oral absorption of the GPIIb/IIIa receptor antagonist, DMP 728, in rats and dogs. Pharm Res 12:2065–2070

    Article  PubMed  CAS  Google Scholar 

  • Chao AC, Nguyen JV, Broughall M, Recchia J, Kensil CR, Daddona PE, Fix JA (1998a) Enhancement of intestinal model compound transport by DS-1, a modified Quillaia saponin. J Pharm Sci 87:1395–1399

    Article  PubMed  CAS  Google Scholar 

  • Chao AC, Taylor MT, Daddona PE, Broughall M, Fix JA (1998b) Molecular weight-dependent paracellular transport of fluorescent model compounds induced by palmitoylcarnitine chloride across the human intestinal epithelial cell line Caco-2. J Drug Targeting 6:37–43

    Article  CAS  Google Scholar 

  • Chao AC, Nguyen JV, Broughall M, Griffin A, Fix JA, Daddona PE (1999) In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int J Pharm 191:15–24

    Article  PubMed  CAS  Google Scholar 

  • Chelminska-Bertilsson M, Edebo A, Thompson RA, Edebo L (1995) Enzymatic hydrolysis of long-chain alkanoylcholines in rat intestinal loops. Scand J Gastroenterol 30:670–674

    Article  PubMed  CAS  Google Scholar 

  • Constantinides PP, Scalart J-P, Lancaster C, Marcello J, Marks G, Ellens H, Smith PL (1994) Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res 11:1385–1390

    Article  PubMed  CAS  Google Scholar 

  • Cox D, Raje S, Gao H, et al. (2002) Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, Zonula Occludens toxin. Pharm Res 19:1680–1688

    Article  PubMed  CAS  Google Scholar 

  • Di Pierro M, Lu R, Uzzau S, et al. (2001) Zonula Occludens toxin structure-function analysis: identification of the fragment biologically active on tight junctions and of the Zonulin receptor binding domain J Biol Chem 276:19160–19165

    Article  PubMed  Google Scholar 

  • Duizer E, Van der Wulp C, Versantvoort CHM, Groten JP (1998) Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. J Pharmacol Exp Ther 287:395–402

    PubMed  CAS  Google Scholar 

  • Fasano A (2001) Intestinal Zonulin: open sesame! Gut 49:159–162

    CAS  Google Scholar 

  • Fasano A, Uzzau S (1997) Modulation of intestinal tight junctions by Zonula Occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 99:1158–1164

    Article  PubMed  CAS  Google Scholar 

  • Fasano A, Baudry B, Pumplin D, et al. (1991) Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA 88:5242–5246

    Article  PubMed  CAS  Google Scholar 

  • Fasano A, Uzzau S, Fiore C, Mararetten K (1997) The enterotoxic effect of Zonula Occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroentrology 112:839–846

    Article  CAS  Google Scholar 

  • Fix JA (1996) Strategies for delivery of peptides utilizing absorption-enhancing agents. J Pharm Sci 85:1282–1285

    Article  PubMed  CAS  Google Scholar 

  • Fix JA, Engle K, Porter PA, Leppert PS, Selk SJ, Gardner CR, Alexander J (1986) Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. Am J Physiol 251:G332–G340

    PubMed  CAS  Google Scholar 

  • Hastewell J, Lynch S, Fox R, Williamson I, Skelton-Stroud P, Mackay M (1994) Enhancement of human calcitonin absorption across the rat colon in vivo. Int J Pharm 101:115–120

    Article  CAS  Google Scholar 

  • Hellriegel ET, Bjornsson TD, Hauck WW (1996) Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clin Pharmacol Ther 60:601–607

    Article  PubMed  CAS  Google Scholar 

  • Hochman JH, Fix JA, LeCluyse EL (1994) In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine. J Pharmacol Exp Ther 269:813–822

    PubMed  CAS  Google Scholar 

  • Hoffman A, Qadri B (2008) Eligen insulin--a system for the oral delivery of insulin for diabetes. IDrugs 11:433–41

    PubMed  CAS  Google Scholar 

  • Imai T, Sakai M, Ohtake H, Azuma H, Otagiri M (1999) In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs. Pharm Res 16:80–86

    Article  PubMed  CAS  Google Scholar 

  • Knipp GT, Ho NFH, Barsuhn CL, Borchardt RT (1997) Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J Pharm Sci 86:1105–1110

    Article  PubMed  CAS  Google Scholar 

  • LeCluyse EL, Sutton SC, Fix JA (1993) In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa. J Pharmacol Exp Ther 265:955–962

    PubMed  CAS  Google Scholar 

  • Leone-Bay A, Paton DR, Freeman J, Lercara C, O’Toole D, Gschneidner D, Wang E, Harris E, Rosado C, Rivera T, et al. (1998a) Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin. J Med Chem 41:1163–1171

    Article  PubMed  CAS  Google Scholar 

  • Leone-Bay A, Paton D, Variano B, Leipold H, Rivera T, Miura-Fraboni J, Baughman RA, Santiago N (1998b) Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP. J Contr Rel 50:41–49

    Article  CAS  Google Scholar 

  • Lin X, Xu DS, Feng Y, Li SM, Lu ZL, Shen L (2006) Release-controlling absorption enhancement of enterally administered Ophiopogon japonicus polysaccharide by sodium caprate in rats. J Pharm Sci 95:2534–42

    Article  PubMed  CAS  Google Scholar 

  • Lindmark T, Nikkilä T, Artursson P (1995) Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 275:958–964

    PubMed  CAS  Google Scholar 

  • Lindmark T, Kimura Y, Artursson P (1998) Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 284:362–369

    PubMed  CAS  Google Scholar 

  • Lindmark T, Schipper N, Lazorová L, de Boer AG, Artursson P (1997) Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes. J Drug Targeting 5:215–223

    Article  Google Scholar 

  • Lohikangas L, Wilen M, Einarsson M, Artursson P (1994) Effects of a new lipid-based drug delivery system on the absorption of low molecular weight heparin (Fragmin) through monolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits. Eur J Pharm Sci 1:297–305

    Article  CAS  Google Scholar 

  • Lundin PDP, Bojrup M, Ljusberg-Wahren H, Weström BR, Lundin S (1997) Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP). J Pharmacol Exp Ther 282:585–590

    PubMed  CAS  Google Scholar 

  • Milstein SJ, Leipold H, Sarubbi D, Leone-Bay A, Mlynek GM, Robinson JR, Kasimova M, Freire E (1998) Partially unfolded proteins efficiently penetrate cell membranes – implications for oral drug delivery. J Contr Rel 53:259–267

    Article  CAS  Google Scholar 

  • Morishita M, Matsuzawa A, Takayama K, Isowa K, Nagai T (1998) Improving insulin enteral absorption using water-in-oil-in-water emulsion. Int J Pharm 172:189–198

    Article  CAS  Google Scholar 

  • Nishihata T, Rytting JH, Kamada A, Higuchi T, Routh M, Caldwell L (1983) Enhancement of rectal absorption of insulin using salicylates in dogs. J Pharm Pharmacol 35:148–151

    Article  PubMed  CAS  Google Scholar 

  • Noach ABJ, Kurosaki Y, Blom-Roosemalen MCM, de Boer AG, Breimer DD (1993) Cell-polarity dependent effect of chelation on the paracellular permeability of confluent Caco-2 cell monolayers. Int J Pharm 90:229–237

    Article  CAS  Google Scholar 

  • Rivera TM, Leone-Bay A, Paton DR, Leipold H, Baughman RA (1997) Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl) amino]caprylate: pharmacological considerations. Pharm Res 14:1830–1834

    Article  PubMed  CAS  Google Scholar 

  • Sakai K, Kutsuna TM, Nishino T, Fujihara Y, Yata N (1986) Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J Pharm Sci 75:387–390

    Article  PubMed  CAS  Google Scholar 

  • Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M (1997) Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J Pharm Sci 86:779–785

    Article  PubMed  CAS  Google Scholar 

  • Sakai M, Imai T, Ohtake H, Otagiri M (1998) Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J Pharm Pharmacol 50:1101–1108

    Article  PubMed  CAS  Google Scholar 

  • Salama NN, Fasano A, Lu R, et al. (2003) Effect of the biologically active fragment of Zonula Occludens toxin, ΔG, on the intestinal paracellular transport and oral absorption of mannitol. Int J. Pharm 251:113–121

    Article  PubMed  CAS  Google Scholar 

  • Salama NN, Fasano A, Thakar M, et al. (2004) The effect of ΔG on the transport and oral absorption of macromolecules. J Pharm Sci 93:1310–1319

    Article  PubMed  CAS  Google Scholar 

  • Salama NN, Fasano A, Thakar M, et al. (2005) The effect of ΔG on the oral bioavailability of low bioavailable therapeutic agents. J Pharmacol Exp Ther 312:199–205

    Article  PubMed  CAS  Google Scholar 

  • Salzman AL, Menconi MJ, Unno N, Ezzell RM, Casey DM, Gonzalez PK, Fink MP (1995) Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 268:G361–G373

    PubMed  CAS  Google Scholar 

  • Sekine M, Maeda E, Sasahara K, Okada R, Kimura K, Fukami M, Awazu S (1985) Improvement of bioavailability of poorly absorbed drugs. III. Oral acute toxicity and local irritation of medium chain glyceride. J Pharmacobio-Dyn 8:633–644

    Article  PubMed  CAS  Google Scholar 

  • Shimazaki T, Tomita M, Sadahiro S, Hayashi M, Awazu S (1998) Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons. Dig Dis Sci 43:641–645

    Article  PubMed  CAS  Google Scholar 

  • Swenson ES, Milisen WB, Curatolo W (1994) Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers. Pharm Res 11:1501–1504

    Article  PubMed  CAS  Google Scholar 

  • Tomita M, Hayashi M, Horie T, Ishizawa T, Awazu S (1988) Enhancement of colonic drug absorption by the transcellular permeation route. Pharm Res 5:786–789

    Article  PubMed  CAS  Google Scholar 

  • Tomita M, Sawada T, Ogawa T, Ouchi H, Hayashi M, Awazu S (1992) Differences in the enhancing effects of sodium caprate on colonic and jejunal drug absorption. Pharm Res 9:648–653

    Article  PubMed  CAS  Google Scholar 

  • Tomita M, Hayashi M, Awazu S (1995) Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells. J Pharmacol Exp Ther 272:739–743

    PubMed  CAS  Google Scholar 

  • Uchiyama T, Yamamoto A, Hatano H, Fujita T, Muranishi S (1996) Effectiveness toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. Biol Pharm Bull 19:1618–1621

    Article  PubMed  CAS  Google Scholar 

  • Utoguchi N, Watanabe Y, Shida T, Matsumoto M (1998) Nitric oxide donors enhance rectal absorption of macromolecules in rabbits. Pharm Res 15:870–876

    Article  PubMed  CAS  Google Scholar 

  • Uzzau S, Fasano A (2000) Cross-talk between enteric pathogens and the intestine. Cell Microbiol 2:83–89

    Article  PubMed  CAS  Google Scholar 

  • Uzzau S, Fiore C, Margaretten K, et al. (1996) Modulation of intestinal tight junctions: a novel mechanism of intestinal secretion. Gastroentrology 110:370

    Google Scholar 

  • Uzzau S, Cappuccinelli P, Fasano A (1999) Expression of Vibrio cholerae Zonula Occludens toxin and analysis of its subcellular localization. Microb Pathog 27:377–385

    Article  PubMed  CAS  Google Scholar 

  • Wang W, Uzzau S, Goldblum S, Fasano A (2000) Human Zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 113:4435–4440

    PubMed  CAS  Google Scholar 

  • Watts TL, Alexander T, Hansen B, et al. (2000) Utilizing the paracellular pathway: a novel approach for the delivery of oral insulin in diabetic rhesus macaques. J Invest Med 48:185

    Google Scholar 

  • Werner U, Kissel T, Reers M (1996) Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2). Pharm Res 13:1219–1227

    Article  PubMed  CAS  Google Scholar 

  • Whitehead K, Mitragotri S (2008) Mechanistic analysis of chemical permeation enhancers for oral drug delivery. Pharm Res 25:1412–1419

    Article  PubMed  CAS  Google Scholar 

  • Whitehead K, Karr N, Mitragotri S (2008) Discovery of synergistic permeation enhancers for oral drug delivery. J Control Rel 128:128–33

    Article  CAS  Google Scholar 

  • Wu S-Y, Robinson JR (1999) Transcellular lipophilic complex-enhanced intestinal absorption of human growth hormone. Pharm Res 16:1266–1272

    Article  PubMed  CAS  Google Scholar 

  • Yamashita S, Saitoh H, Nakanishi K, Masada M, Nadai T, Kimura T (1987) Effects of diclofenac sodium and disodium ethylenediaminetetraacetate on electrical parameters of the mucosal membrane and their relation to the permeability enhancing effects in the rat jejunum. J Pharm Pharmacol 39:621–626

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Fujita T, Murakami M, Muranishi S (1994) Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 11:1496–1500

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto A, Uchiyama T, Nishikawa R, Fujita T, Muranishi S (1996) Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J Pharm Pharmacol 48:1285–1289

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto A, Okagawa T, Kotani A, Uchiyama T, Shimura T, Tabata S, Kondo S, Muranishi S (1997) Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. J Pharm Pharmacol 49:1057–1061

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto A, Tatsumi H, Maruyama M, Uchiyama T, Okada N, Fujita T (2001) Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. J Pharmacol Exp Ther 296:84–90

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacy, University of Innsbruck, Innrain 52, 6020, Innsbruck, Austria

    Andreas Bernkop-Schnürch

Authors
  1. Andreas Bernkop-Schnürch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Bernkop-Schnürch .

Editor information

Editors and Affiliations

  1. Naturwissenschaftliche Fakultät, Universität Innsbruck, Innrain 52, Innsbruck, 6020, Austria

    Andreas Bernkop-Schnürch

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bernkop-Schnürch, A. (2009). Low Molecular Mass Permeation Enhancers in Oral Delivery of Macromolecular Drugs. In: Bernkop-Schnürch, A. (eds) Oral Delivery of Macromolecular Drugs. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0200-9_5

Download citation

Publish with us

Policies and ethics

Search

Navigation